Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników

Znaleziono wyników: 47

Liczba wyników na stronie
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 3 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników

Wyniki wyszukiwania

help Sortuj według:

help Ogranicz wyniki do:
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 3 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
The World Health Organization (WHO) announced on May 8, 1980 that the smallpox virus (VARV) had been eradicated from the environment. This was possible after the spectacular success of the Intensified Smallpox Eradication Program initiated in 1967 by WHO. In this mini review the history of smallpox variolation and vaccination is summarized. The status quo in this matter is discussed as well as the hypothetical situation connected with the possibility of the reintroduction of VARV to nature. Some attention is given to Dr. Edward Jenner (1749-1823), the father of immunology and one of the world’s greatest scientific visionaries who was well ahead of his time.
Bioterrorist attacks could be catastrophic not only for the people (bioterrorism), but also for animals and plants (agroterrorism) and for economy of each country (national security). In this paper we have focused on two viruses extremely important from the veterinary point of view: (i) foot-and-mouth disease virus (FMDV; virus RNA) and (ii) African swine fever virus (ASFV; virus DNA), that are excellent examples of very dangerous infectious agents that can be used as a biological weapon for agroterrorist attacks.
Medycyna Weterynaryjna
|
2010
|
tom 66
|
nr 12
s.810-817,rys.,tab.,bibliogr.
Tumors are one of the most important health problems for man and animals in the context of human health protection and food hygiene. It is well known that cancer diseases depend on genetic background and subtle molecular regulation of cell division and can be induced by three groups of carcinogens: biological (i.e. some viruses known as oncogenic viruses), physical and chemical. To date more than 50 various DNA (i.e. herpesviruses, adenoviruses, papillomaviriruses and polyomaviriruses) and RNA (retroviruses) viruses have been well documented as oncogenic viruses. Viruses (i.e. oncogenic herpesviruses and retroviruses) have evolved long-term survival strategies (latency) in the infected host. In the 1970s oncogen v-src of Rous sarcoma virus (RSV) were identified as a factor that can transform the cells of an infected host. At present we know more than 100 viral oncogens (v-jun) and antioncogens (tumor-supressor genes), that compete in cancer induction or supression, respectively. In contrast normal growth promoting genes (the host genes termed protooncogens, c-jun: i.e. growth factors, growth factor receptors and transcriptional factors) have been identified. Thus viral carcinogens can trigger oncogenesis by indirect (i.e. induction of immunosupression in the case of Kaposis’s sarcoma in HIV⁺/AIDS⁺ patients or by modification of host cell genome) or direct (i.e. altering the expression of host cell proteins at the point of viral DNA integration) mechanisms. Different molecular models of the replication of DNA and RNA viruses are essential for oncogenesis development in the infected cells and can influence the frequency of cancer induction. In contrast to RNA viral carcinogens DNA viruses are less efficient in tumor induction because the progeny of RNA viruses are continually being released from the virally transformed cells. In this paper the molecular mechanisms of viral oncogenesis in the context of human (EBV, HPV, HCV, HTLV-1) or animal (RSV, AMV, MDV) viruses is briefly described and discussed.
Medycyna Weterynaryjna
|
2010
|
tom 66
|
nr 11
s.751-755,rys.,bibliogr.
Inflammations of the bovine mammary gland (mastitis) in a milking herd caused by bacterial and fungal infections contribute to economic losses and remain a big challenge for veterinary medicine. Microorganisms have developed a number of strategies in order to evade the immune response of the host, which makes them significantly difficult to eliminate from the infected host. The intranuclear transcription factor NF-κB (nuclear factor κB) is one of the key elements that participate in inflammatory processes. Numerous studies have confirmed the activation of NF-κB by both gram-positive, mainly Staphylococcus aureus, and gram-negative bacteria, such as e.g. Escherichia coli. The activation of NF-κB is a result of the interaction of pathogen-associated molecular patterns (PAMP), such as LPS (lipopolysaccharides) and LTA (lipoteichoic acid), with particular cell surface receptors (TLRs, toll-like receptors). Staphylococcus aureus and Escherichia coli are responsible for chronic and acute forms of this disease, respectively. This article presents a review of the literature on different research methods: ex vivo (milk examination), in vitro (studies on cell cultures) and in vivo (mouse research models). Studies presented here showed different levels of NF-κB activation in inflammatory mechanisms linked to the activation of neutrophils (PMNs, polymorphonuclear cells) in which epithelial and endothelial cells of the mammary gland are also involved. Moreover, the use of transgenic mice for the detection of NF-κB activity in real time and the studies of apoptosis in the mammary gland are presented in this work. Additionally, the article discusses the influence of mastitis therapy on NF-κB activation. Results of the research on the biological role of NF-κB in described immune mechanisms that are linked to mastitis suggest their usefulness for developing efficient therapeutic strategies (prevention and efficient therapy).
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 3 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.